Table 3. Cognitive and neuropsychiatric data (baseline and after 6 months).

Cognitive intervention	Mean (SD) baseline	Mean (SD) after 6 months	p-value
Yes (n=19)
MoCA
Global score	22.1 (6.0)	23.3 (5.3)	0.022*
<26	18.7 (5.0)	21.4 (5.2)	0.019*
18-25	21.8 (1.6)	24.4 (2.5)	0.021*
10-17	14.0 (2.9)	16.0 (4.2)	0.842
≥26	27.9 (1.3)	27.8 (2.3)	0.579
TMT
A sec	99.6 (83.4)	86.4 (49.4)	0.804
A errors	0.7 (1.1)	16.3 (57.5)	0.393
B sec	175.2 (116.1)	164.0 (72.4)	0.412
B errors	1.9 (1.6)	1.4 (1.8)	0.046*
(B-A)	75.5 (45.2)	77.6 (49.8)	0.262
Verbal fluency
Categorical (animals)	14.6 (5.4)	15.7 (6.9)	0.060
HAD
Depression	9.2 (4.8)	7.6 (3.7)	0.366
Anxiety	10.0 (5.2)	9.3 (5.1)	0.262
No (n=10)
MoCA
Global score	22.0 (5.7)	22.2 (7.4)	0.915
<26	19.0 (5.0)	18.1 (8.1)	1.000
18-25	21.8 (2.8)	22.0 (4.7)	0.396
10-17	15.8 (1.26)	13.0 (-)	0.317
≥26	27.4 (1.4)	27.0 (1.7)	0.831
TMT
A sec	94.4 (68.1)	92.6 (57.3)	0.917
A errors	0.7 (1.1)	0.4 (1.0)	0.152
B sec	173.9 (95.5)	157.8 (64.8)	0.235
B errors	2.1 (1.7)	2.0 (1.8)	0.271
(B-A)	79.5 (56.7)	65.1 (32.3)	0.452
Verbal fluency
Categorical (animals)	16.0 (7.7)	17.2 (7.5)	0.417
HAD
Depression	9.3 (5.6)	7.5 (4.8)	0.587
Anxiety	9.5 (4.4)	9.8 (5.1)	0.526

Abbreviations: MoCA, Montreal Cognitive Assessment; TMT, Trail Making Test; HAD, Hospital Depression and Anxiety Scale.

Notes: Wilcoxon test (Wilcoxon matched-pairs or Wilcoxon signed-rank test). *Significance level <0.05.